Initial respiratory status in hyperleukocytic acute myeloid leukemia: prognostic significance and effect of leukapheresis

References

• Dutcher JP, Schiffer CA, Wiernik PH. Hyperleukocytosis in adult acute nonlymphocytic leukemia: impact on remission rate and duration, and survival. J Clin Oncol 1987; 5: 1364–1372.
   PubMed Web of Science ®Google Scholar
• Creutzig U, Ritter J, Budde M, et al. Early deaths due to hemorrhage and leukostasis in childhood acute myelogenous leukemia. Associations with hyperleukocytosis and acute monocytic leukemia. Cancer 1987; 60: 3071–3079.
   PubMed Web of Science ®Google Scholar
• Thiebaut A, Thomas X, Belhabri A, et al. Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis. Ann Hematol 2000; 79: 501–506.
   PubMed Web of Science ®Google Scholar
• Kuo KH, Callum JL, Panzarella T, et al. A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis. Br J Haematol 2015; 168: 384–394.
   PubMed Web of Science ®Google Scholar
• Bug G, Anargyrou K, Tonn T, et al. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis. Transfusion 2007; 47: 1843–1850.
   PubMed Web of Science ®Google Scholar
• Porcu P, Danielson CF, Orazi A, et al. Therapeutic leukapheresis in hyperleucocytic leukaemias: lack of correlation between degree of cytoreduction and early mortality rate. Br J Haematol 1997; 98: 433–436.
   PubMed Web of Science ®Google Scholar
• Rollig C, Ehninger G. How I treat hyperleukocytosis in acute myeloid leukemia. Blood 2015; 125: 3246–3252.
   PubMed Web of Science ®Google Scholar
• Pastore F, Pastore A, Wittmann G, et al. The role of therapeutic leukapheresis in hyperleukocytotic AML. PLoS One 2014; 9: e95062.
   PubMed Web of Science ®Google Scholar
• Marbello L, Ricci F, Nosari AM, et al. Outcome of hyperleukocytic adult acute myeloid leukaemia: a single-center retrospective study and review of literature. Leuk Res 2008; 32: 1221–1227.
   PubMed Web of Science ®Google Scholar
• Porcu P, Cripe LD, Ng EW, et al. Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management. Leuk Lymphoma 2000; 39: 1–18.
   PubMed Web of Science ®Google Scholar
• Oberoi S, Lehrnbecher T, Phillips B, et al. Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: a systematic review and meta-analysis. Leuk Res 2014; 38: 460–468.
   PubMed Web of Science ®Google Scholar
• Van Rybroek JJ, Olson JD, Burns CP. White cell fragmentation after therapeutic leukapheresis for acute leukemia. Transfusion 1987; 27: 353–355.
   PubMed Web of Science ®Google Scholar
• Vernant JP, Brun B, Mannoni P, et al. Respiratory distress of hyperleukocytic granulocytic leukemias. Cancer 1979; 44: 264–268.
   PubMed Web of Science ®Google Scholar
• Kallstrom TJ, American Association for Respiratory C. AARC Clinical Practice Guideline: oxygen therapy for adults in the acute care facility–2002 revision & update. Respir Care 2002; 47: 717–720.
   PubMedGoogle Scholar
• Cheson BD, Bennett JM, Kopecky KJ, et al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol 2003; 21: 4642–4649.
   PubMed Web of Science ®Google Scholar
• Sekeres MA, Elson P, Kalaycio ME, et al. Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients. Blood 2009; 113: 28–36.
   PubMed Web of Science ®Google Scholar
• Bertoli S, Berard E, Huguet F, et al. Time from diagnosis to intensive chemotherapy initiation does not adversely impact the outcome of patients with acute myeloid leukemia. Blood 2013; 121: 2618–2626.
   PubMed Web of Science ®Google Scholar
• Swihart BJ, Caffo B, James BD, et al. Lasagna plots: a saucy alternative to spaghetti plots. Epidemiology 2010; 21: 621–625.
   PubMed Web of Science ®Google Scholar
• Chaoui D, Legrand O, Roche N, et al. Incidence and prognostic value of respiratory events in acute leukemia. Leukemia 2004; 18: 670–675.
   PubMed Web of Science ®Google Scholar
• Al Ameri A, Koller C, Kantarjian H, et al. Acute pulmonary failure during remission induction chemotherapy in adults with acute myeloid leukemia or high-risk myelodysplastic syndrome. Cancer 2010; 116: 93–97.
   PubMed Web of Science ®Google Scholar
• Moreau AS, Lengline E, Seguin A, et al. Respiratory events at the earliest phase of acute myeloid leukemia. Leuk Lymphoma 2014; 55: 2556–2563.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Fieux F, Moreau D, et al. Acute monocytic leukemia presenting as acute respiratory failure. Am J Respir Crit Care Med 2003; 167: 1329–1333.
   PubMed Web of Science ®Google Scholar
• Giles FJ, Shen Y, Kantarjian HM, et al. Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long- term survival. Leuk Lymphoma 2001; 42: 67–73.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Canet E, Raffoux E, et al. Dexamethasone in patients with acute lung injury from acute monocytic leukaemia. Eur Respir J 2012; 39: 648–653.
   PubMed Web of Science ®Google Scholar
• Myers TJ, Cole SR, Klatsky AU, Hild DH. Respiratory failure due to pulmonary leukostasis following chemotherapy of acute nonlymphocytic leukemia. Cancer 1983; 51: 1808–1813.
   PubMed Web of Science ®Google Scholar
• Bunin NJ, Pui CH. Differing complications of hyperleukocytosis in children with acute lymphoblastic or acute nonlymphoblastic leukemia. J Clin Oncol 1985; 3: 1590–1595.
   PubMed Web of Science ®Google Scholar
• Van de Louw A, Desai R, Schneider C, Claxton D. Hypoxemia during extreme hyperleukocytosis: how spurious? Resp Care 2015. [Epub ahead of print]. doi: 10.4187/respcare.04196.
   PubMed Web of Science ®Google Scholar